IGF2

Chr 11AD

insulin like growth factor 2

Also known as: C11orf43, GRDF, IGF-II, PP9974, SRS3

This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 1.131 OMIM phenotype
Clinical SummaryIGF2
🧬
Gene-Disease Validity (ClinGen)
Silver-Russell syndrome 3 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.04) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
25 unique Pathogenic / Likely Pathogenic· 112 VUS of 209 total submissions
💊
Clinical Trials
2 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — IGF2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.13LOEUF
pLI 0.044
Z-score 1.36
OE 0.44 (0.201.13)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.93Z-score
OE missense 0.79 (0.690.92)
127 obs / 160.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.44 (0.201.13)
00.351.4
Missense OE?0.79 (0.690.92)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 3 / 6.8Missense obs/exp: 127 / 160.2Syn Z: -0.02
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveIGF2-related Silver-Russell syndromeLOFAD
definitiveIGF2-related Beckwith-Wiedemann syndromeGOFAD

This gene — mechanism propensity

DN
0.73top 25%
GOF
0.4972th %ile
LOF
0.3453th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNThese mutants suppressed proliferation induced by WT IGF2, suggesting that they are dominant-negative antagonists of IGF1R.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 28873464

ClinVar Variant Classifications

209 submitted variants in ClinVar

Classification Summary

Pathogenic14
Likely Pathogenic11
VUS112
Likely Benign54
Benign8
Conflicting10
14
Pathogenic
11
Likely Pathogenic
112
VUS
54
Likely Benign
8
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
10
2
2
0
14
Likely Pathogenic
8
3
0
0
11
VUS
8
97
6
1
112
Likely Benign
0
7
5
42
54
Benign
0
0
4
4
8
Conflicting
10
Total261091747209

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

31 pathogenic / likely-pathogenic (of 45) ClinVar copy-number / structural variants overlap IGF2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

IGF2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.